Close Menu

Beckman Coulter

Wayne Cowens joined NanoString from Genomic Health this week, while Roche proposed new members for its board of directors, and BioNanomatrix hired Erik Holmlin as its new CEO; and more.

The announcement follows developments last year in which next-gen sequencing uncovered fragments of a porcine circovirus within a rotavirus vaccine, prompting the US Food and Drug Administration to consider the use of sequencing as a quality-control measure for vaccines and biologics.

Its time estimate is based on the current status of its clinical trial for the test, including site and patient enrolment, and preliminary myocardial infarction incidence rates observed.

The test under development will be used in an upcoming clinical trial to determine which patients may be suitable for treatment with an immunotherapy candidate for non-small cell lung cancer.

Transgene plans to use the tests from Ventana and Beckman Coulter to analyze which subpopulations of patients with advanced NSCLC will likely respond best to the MVA-MUC1-IL2 immunotherapeutic in combination with first-line therapy.

Overall, the GWDN Index was up more than 10 percent for the month, while the broader stock market also saw significant gains.

New Products: Dec 14, 2010

Premium

Beckman Coulters' SPRIworks Fragment Library System, Complete Genomics' CNV and SV analysis, Ambry Genetics' sequencing services on HiSeq 2000, EdgeBio a CSP for Agilent's SureSelect Target Enrichment System

A potential sale of the company could fetch more than $5 million.

The new platform, called Panther, is expected to help Gen-Probe capture market share in the area of molecular testing at mid- and low-volume clinical laboratories, clinics, and physicians' offices as it competes with platforms from companies such as Roche, Qiagen, Cepheid, and Becton Dickinson.

The RFP is "targeting large-scale sequencing centers or a consortium of academic and/or commercial centers that are believed to have the expertise and capacity to participate in a project of this scale."

Pages

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.